世界の疾病管理・予防用ワクチン市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Disease Control and Prevention Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z04495 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、疾病管理・予防用ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。疾病管理・予防用ワクチンの種類別市場規模（生弱毒化、不活化、組換えサブユニット・トキソイド）、用途別市場規模（小児用ワクチン、成人用ワクチン）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・疾病管理・予防用ワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：GSK、Merck & Co., Inc、Pfizer、Sanofi、AstraZeneca PLC、Sinovac Biotech Ltd、Astellas Pharma Inc、Serum Institute of India Pvt. Ltd、Daiichi Sankyo ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：生弱毒化、不活化、組換えサブユニット・トキソイド ・用途別分析2016年-2026年：小児用ワクチン、成人用ワクチン ・疾病管理・予防用ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・疾病管理・予防用ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・疾病管理・予防用ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・疾病管理・予防用ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・疾病管理・予防用ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Disease Control and Prevention Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Disease Control and Prevention Vaccine size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Disease Control and Prevention Vaccine market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Disease Control and Prevention Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Live-Attenuated
Inactivated
Recombinant Sub Unit and Toxoid

Market segment by Application can be divided into
Pediatric Vaccine
Adult Vaccine

The key market players for global Disease Control and Prevention Vaccine market are listed below:
GSK
Merck & Co., Inc
Pfizer
Sanofi
AstraZeneca PLC
Sinovac Biotech Ltd
Astellas Pharma Inc
Serum Institute of India Pvt. Ltd
Daiichi Sankyo

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Disease Control and Prevention Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Disease Control and Prevention Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Live-Attenuated
1.2.3 Inactivated
1.2.4 Recombinant Sub Unit and Toxoid
1.3 Market Analysis by Application
1.3.1 Overview: Global Disease Control and Prevention Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Pediatric Vaccine
1.3.3 Adult Vaccine
1.4 Global Disease Control and Prevention Vaccine Market Size & Forecast
1.4.1 Global Disease Control and Prevention Vaccine Sales in Value (2016-2026))
1.4.2 Global Disease Control and Prevention Vaccine Sales in Volume (2016-2026)
1.4.3 Global Disease Control and Prevention Vaccine Price by Type (2016-2026) & (USD/Unit)
1.5 Global Disease Control and Prevention Vaccine Production Capacity Analysis
1.5.1 Global Disease Control and Prevention Vaccine Total Production Capacity (2016-2026)
1.5.2 Global Disease Control and Prevention Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Disease Control and Prevention Vaccine Market Drivers
1.6.2 Disease Control and Prevention Vaccine Market Restraints
1.6.3 Disease Control and Prevention Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Disease Control and Prevention Vaccine Product and Services
2.1.4 GSK Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Merck & Co., Inc
2.2.1 Merck & Co., Inc Details
2.2.2 Merck & Co., Inc Major Business
2.2.3 Merck & Co., Inc Disease Control and Prevention Vaccine Product and Services
2.2.4 Merck & Co., Inc Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Disease Control and Prevention Vaccine Product and Services
2.3.4 Pfizer Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Disease Control and Prevention Vaccine Product and Services
2.4.4 Sanofi Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 AstraZeneca PLC
2.5.1 AstraZeneca PLC Details
2.5.2 AstraZeneca PLC Major Business
2.5.3 AstraZeneca PLC Disease Control and Prevention Vaccine Product and Services
2.5.4 AstraZeneca PLC Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Sinovac Biotech Ltd
2.6.1 Sinovac Biotech Ltd Details
2.6.2 Sinovac Biotech Ltd Major Business
2.6.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product and Services
2.6.4 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Astellas Pharma Inc
2.7.1 Astellas Pharma Inc Details
2.7.2 Astellas Pharma Inc Major Business
2.7.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Product and Services
2.7.4 Astellas Pharma Inc Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Serum Institute of India Pvt. Ltd
2.8.1 Serum Institute of India Pvt. Ltd Details
2.8.2 Serum Institute of India Pvt. Ltd Major Business
2.8.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product and Services
2.8.4 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Daiichi Sankyo
2.9.1 Daiichi Sankyo Details
2.9.2 Daiichi Sankyo Major Business
2.9.3 Daiichi Sankyo Disease Control and Prevention Vaccine Product and Services
2.9.4 Daiichi Sankyo Disease Control and Prevention Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Disease Control and Prevention Vaccine Sales by Manufacturer
3.1 Global Disease Control and Prevention Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Disease Control and Prevention Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Disease Control and Prevention Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Disease Control and Prevention Vaccine Manufacturer Market Share
3.4.2 Top 6 Disease Control and Prevention Vaccine Manufacturer Market Share
3.5 Global Disease Control and Prevention Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Disease Control and Prevention Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Disease Control and Prevention Vaccine Market Size by Region
4.1.1 Global Disease Control and Prevention Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global Disease Control and Prevention Vaccine Revenue by Region (2016-2026)
4.2 North America Disease Control and Prevention Vaccine Revenue (2016-2026)
4.3 Europe Disease Control and Prevention Vaccine Revenue (2016-2026)
4.4 Asia-Pacific Disease Control and Prevention Vaccine Revenue (2016-2026)
4.5 South America Disease Control and Prevention Vaccine Revenue (2016-2026)
4.6 Middle East and Africa Disease Control and Prevention Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Disease Control and Prevention Vaccine Sales in Volume by Type (2016-2026)
5.2 Global Disease Control and Prevention Vaccine Revenue by Type (2016-2026)
5.3 Global Disease Control and Prevention Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Disease Control and Prevention Vaccine Sales in Volume by Application (2016-2026)
6.2 Global Disease Control and Prevention Vaccine Revenue by Application (2016-2026)
6.3 Global Disease Control and Prevention Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Disease Control and Prevention Vaccine Sales by Type (2016-2026)
7.2 North America Disease Control and Prevention Vaccine Sales by Application (2016-2026)
7.3 North America Disease Control and Prevention Vaccine Market Size by Country
7.3.1 North America Disease Control and Prevention Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America Disease Control and Prevention Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Disease Control and Prevention Vaccine Sales by Type (2016-2026)
8.2 Europe Disease Control and Prevention Vaccine Sales by Application (2016-2026)
8.3 Europe Disease Control and Prevention Vaccine Market Size by Country
8.3.1 Europe Disease Control and Prevention Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe Disease Control and Prevention Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Disease Control and Prevention Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific Disease Control and Prevention Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific Disease Control and Prevention Vaccine Market Size by Region
9.3.1 Asia-Pacific Disease Control and Prevention Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Disease Control and Prevention Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Disease Control and Prevention Vaccine Sales by Type (2016-2026)
10.2 South America Disease Control and Prevention Vaccine Sales by Application (2016-2026)
10.3 South America Disease Control and Prevention Vaccine Market Size by Country
10.3.1 South America Disease Control and Prevention Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America Disease Control and Prevention Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Disease Control and Prevention Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa Disease Control and Prevention Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country
11.3.1 Middle East & Africa Disease Control and Prevention Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Disease Control and Prevention Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Disease Control and Prevention Vaccine Typical Distributors
12.3 Disease Control and Prevention Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Disease Control and Prevention Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Disease Control and Prevention Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Disease Control and Prevention Vaccine Product and Services
Table 6. GSK Disease Control and Prevention Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 8. Merck & Co., Inc Major Business
Table 9. Merck & Co., Inc Disease Control and Prevention Vaccine Product and Services
Table 10. Merck & Co., Inc Disease Control and Prevention Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Disease Control and Prevention Vaccine Product and Services
Table 14. Pfizer Disease Control and Prevention Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Sanofi Basic Information, Manufacturing Base and Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi Disease Control and Prevention Vaccine Product and Services
Table 18. Sanofi Disease Control and Prevention Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. AstraZeneca PLC Basic Information, Manufacturing Base and Competitors
Table 20. AstraZeneca PLC Major Business
Table 21. AstraZeneca PLC Disease Control and Prevention Vaccine Product and Services
Table 22. AstraZeneca PLC Disease Control and Prevention Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Sinovac Biotech Ltd Basic Information, Manufacturing Base and Competitors
Table 24. Sinovac Biotech Ltd Major Business
Table 25. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product and Services
Table 26. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Astellas Pharma Inc Basic Information, Manufacturing Base and Competitors
Table 28. Astellas Pharma Inc Major Business
Table 29. Astellas Pharma Inc Disease Control and Prevention Vaccine Product and Services
Table 30. Astellas Pharma Inc Disease Control and Prevention Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Serum Institute of India Pvt. Ltd Basic Information, Manufacturing Base and Competitors
Table 32. Serum Institute of India Pvt. Ltd Major Business
Table 33. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product and Services
Table 34. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 36. Daiichi Sankyo Major Business
Table 37. Daiichi Sankyo Disease Control and Prevention Vaccine Product and Services
Table 38. Daiichi Sankyo Disease Control and Prevention Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Disease Control and Prevention Vaccine Sales by Manufacturer (2019-2021e) & (K Units)
Table 40. Global Disease Control and Prevention Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Disease Control and Prevention Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Disease Control and Prevention Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Disease Control and Prevention Vaccine Production Site of Key Manufacturer
Table 44. Global Disease Control and Prevention Vaccine Sales by Region (2016-2021e) & (K Units)
Table 45. Global Disease Control and Prevention Vaccine Sales by Region (2021-2026) & (K Units)
Table 46. Global Disease Control and Prevention Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 47. Global Disease Control and Prevention Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 48. Global Disease Control and Prevention Vaccine Sales by Type (2016-2021e) & (K Units)
Table 49. Global Disease Control and Prevention Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Global Disease Control and Prevention Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 51. Global Disease Control and Prevention Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 52. Global Disease Control and Prevention Vaccine Price by Type (2016-2021e) & (USD/Unit)
Table 53. Global Disease Control and Prevention Vaccine Price by Type (2021-2026) & (USD/Unit)
Table 54. Global Disease Control and Prevention Vaccine Sales by Application (2016-2021e) & (K Units)
Table 55. Global Disease Control and Prevention Vaccine Sales by Application (2021-2026) & (K Units)
Table 56. Global Disease Control and Prevention Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 57. Global Disease Control and Prevention Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 58. Global Disease Control and Prevention Vaccine Price by Application (2016-2021e) & (USD/Unit)
Table 59. Global Disease Control and Prevention Vaccine Price by Application (2021-2026) & (USD/Unit)
Table 60. North America Disease Control and Prevention Vaccine Sales by Country (2016-2021e) & (K Units)
Table 61. North America Disease Control and Prevention Vaccine Sales by Country (2021-2026) & (K Units)
Table 62. North America Disease Control and Prevention Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 63. North America Disease Control and Prevention Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 64. North America Disease Control and Prevention Vaccine Sales by Type (2016-2021e) & (K Units)
Table 65. North America Disease Control and Prevention Vaccine Sales by Type (2021-2026) & (K Units)
Table 66. North America Disease Control and Prevention Vaccine Sales by Application (2016-2021e) & (K Units)
Table 67. North America Disease Control and Prevention Vaccine Sales by Application (2021-2026) & (K Units)
Table 68. Europe Disease Control and Prevention Vaccine Sales by Country (2016-2021e) & (K Units)
Table 69. Europe Disease Control and Prevention Vaccine Sales by Country (2021-2026) & (K Units)
Table 70. Europe Disease Control and Prevention Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 71. Europe Disease Control and Prevention Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 72. Europe Disease Control and Prevention Vaccine Sales by Type (2016-2021e) & (K Units)
Table 73. Europe Disease Control and Prevention Vaccine Sales by Type (2021-2026) & (K Units)
Table 74. Europe Disease Control and Prevention Vaccine Sales by Application (2016-2021e) & (K Units)
Table 75. Europe Disease Control and Prevention Vaccine Sales by Application (2021-2026) & (K Units)
Table 76. Asia-Pacific Disease Control and Prevention Vaccine Sales by Region (2016-2021e) & (K Units)
Table 77. Asia-Pacific Disease Control and Prevention Vaccine Sales by Region (2021-2026) & (K Units)
Table 78. Asia-Pacific Disease Control and Prevention Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 79. Asia-Pacific Disease Control and Prevention Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Disease Control and Prevention Vaccine Sales by Type (2016-2021e) & (K Units)
Table 81. Asia-Pacific Disease Control and Prevention Vaccine Sales by Type (2021-2026) & (K Units)
Table 82. Asia-Pacific Disease Control and Prevention Vaccine Sales by Application (2016-2021e) & (K Units)
Table 83. Asia-Pacific Disease Control and Prevention Vaccine Sales by Application (2021-2026) & (K Units)
Table 84. South America Disease Control and Prevention Vaccine Sales by Country (2016-2021e) & (K Units)
Table 85. South America Disease Control and Prevention Vaccine Sales by Country (2021-2026) & (K Units)
Table 86. South America Disease Control and Prevention Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 87. South America Disease Control and Prevention Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 88. South America Disease Control and Prevention Vaccine Sales by Type (2016-2021e) & (K Units)
Table 89. South America Disease Control and Prevention Vaccine Sales by Type (2021-2026) & (K Units)
Table 90. South America Disease Control and Prevention Vaccine Sales by Application (2016-2021e) & (K Units)
Table 91. South America Disease Control and Prevention Vaccine Sales by Application (2021-2026) & (K Units)
Table 92. Middle East & Africa Disease Control and Prevention Vaccine Sales by Country (2016-2021e) & (K Units)
Table 93. Middle East & Africa Disease Control and Prevention Vaccine Sales by Country (2021-2026) & (K Units)
Table 94. Middle East & Africa Disease Control and Prevention Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 95. Middle East & Africa Disease Control and Prevention Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Disease Control and Prevention Vaccine Sales by Type (2016-2021e) & (K Units)
Table 97. Middle East & Africa Disease Control and Prevention Vaccine Sales by Type (2021-2026) & (K Units)
Table 98. Middle East & Africa Disease Control and Prevention Vaccine Sales by Application (2016-2021e) & (K Units)
Table 99. Middle East & Africa Disease Control and Prevention Vaccine Sales by Application (2021-2026) & (K Units)
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Disease Control and Prevention Vaccine Typical Distributors
Table 103. Disease Control and Prevention Vaccine Typical Customers
List of Figures
Figure 1. Disease Control and Prevention Vaccine Picture
Figure 2. Global Disease Control and Prevention Vaccine Sales Market Share by Type in 2020
Figure 3. Live-Attenuated
Figure 4. Inactivated
Figure 5. Recombinant Sub Unit and Toxoid
Figure 6. Global Disease Control and Prevention Vaccine Sales Market Share by Application in 2020
Figure 7. Pediatric Vaccine
Figure 8. Adult Vaccine
Figure 9. Global Disease Control and Prevention Vaccine Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Disease Control and Prevention Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Disease Control and Prevention Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Disease Control and Prevention Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Disease Control and Prevention Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Disease Control and Prevention Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Disease Control and Prevention Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Disease Control and Prevention Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Disease Control and Prevention Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Disease Control and Prevention Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Disease Control and Prevention Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Disease Control and Prevention Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Disease Control and Prevention Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Disease Control and Prevention Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Disease Control and Prevention Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Disease Control and Prevention Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Disease Control and Prevention Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Disease Control and Prevention Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Disease Control and Prevention Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Disease Control and Prevention Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Disease Control and Prevention Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Disease Control and Prevention Vaccine Sales (2016-2026) & (K Units)
Figure 31. Global Disease Control and Prevention Vaccine Production Capacity (2016-2026) & (K Units)
Figure 32. Global Disease Control and Prevention Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Disease Control and Prevention Vaccine Market Drivers
Figure 34. Disease Control and Prevention Vaccine Market Restraints
Figure 35. Disease Control and Prevention Vaccine Market Trends
Figure 36. Global Disease Control and Prevention Vaccine Sales Market Share by Manufacturer in 2020
Figure 37. Global Disease Control and Prevention Vaccine Revenue Market Share by Manufacturer in 2020
Figure 38. Disease Control and Prevention Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Disease Control and Prevention Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Disease Control and Prevention Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Disease Control and Prevention Vaccine Sales Market Share by Region (2016-2026)
Figure 42. Global Disease Control and Prevention Vaccine Revenue Market Share by Region (2016-2026)
Figure 43. North America Disease Control and Prevention Vaccine Revenue (2016-2026) & (USD Million)
Figure 44. Europe Disease Control and Prevention Vaccine Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Disease Control and Prevention Vaccine Revenue (2016-2026) & (USD Million)
Figure 46. South America Disease Control and Prevention Vaccine Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Disease Control and Prevention Vaccine Revenue (2016-2026) & (USD Million)
Figure 48. Global Disease Control and Prevention Vaccine Sales Market Share by Type (2016-2026)
Figure 49. Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2016-2026)
Figure 50. Global Disease Control and Prevention Vaccine Price by Type (2016-2026) & (USD/Unit)
Figure 51. Global Disease Control and Prevention Vaccine Sales Market Share by Application (2016-2026)
Figure 52. Global Disease Control and Prevention Vaccine Revenue Market Share by Application (2016-2026)
Figure 53. Global Disease Control and Prevention Vaccine Price by Application (2016-2026) & (USD/Unit)
Figure 54. North America Disease Control and Prevention Vaccine Sales Market Share by Country (2016-2026)
Figure 55. North America Disease Control and Prevention Vaccine Revenue Market Share by Country (2016-2026)
Figure 56. North America Disease Control and Prevention Vaccine Sales Market Share by Type (2016-2026)
Figure 57. North America Disease Control and Prevention Vaccine Sales Market Share by Application (2016-2026)
Figure 58. Europe Disease Control and Prevention Vaccine Sales Market Share by Country (2016-2026)
Figure 59. Europe Disease Control and Prevention Vaccine Revenue Market Share by Country (2016-2026)
Figure 60. Europe Disease Control and Prevention Vaccine Sales Market Share by Type (2016-2026)
Figure 61. Europe Disease Control and Prevention Vaccine Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Disease Control and Prevention Vaccine Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Disease Control and Prevention Vaccine Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Disease Control and Prevention Vaccine Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Disease Control and Prevention Vaccine Sales Market Share by Application (2016-2026)
Figure 66. South America Disease Control and Prevention Vaccine Sales Market Share by Country (2016-2026)
Figure 67. South America Disease Control and Prevention Vaccine Revenue Market Share by Country (2016-2026)
Figure 68. South America Disease Control and Prevention Vaccine Sales Market Share by Type (2016-2026)
Figure 69. South America Disease Control and Prevention Vaccine Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Disease Control and Prevention Vaccine Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Disease Control and Prevention Vaccine Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Disease Control and Prevention Vaccine Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Disease Control and Prevention Vaccine Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source

---